RAPT Therapeutics, Inc. (RAPT) Other Gross PP&E Adjustments (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with $7.4 million as the latest value for Q3 2024.
- Quarterly Other Gross PP&E Adjustments rose 32.76% to $7.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Sep 2024, up 32.76% year-over-year, with the annual reading at $349000.0 for FY2023, 1617.39% up from the prior year.
- Other Gross PP&E Adjustments hit $7.4 million in Q3 2024 for RAPT Therapeutics, up from $6.9 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.0 million in Q1 2021 to a low of -$23000.0 in Q4 2022.
- Historically, Other Gross PP&E Adjustments has averaged $6.5 million across 5 years, with a median of $6.9 million in 2024.
- Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 100.28% in 2022 and later soared 1617.39% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at $8.8 million in 2020, then decreased by 7.93% to $8.1 million in 2021, then crashed by 100.28% to -$23000.0 in 2022, then skyrocketed by 1617.39% to $349000.0 in 2023, then skyrocketed by 2017.77% to $7.4 million in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for RAPT at $7.4 million in Q3 2024, $6.9 million in Q2 2024, and $6.6 million in Q1 2024.